Related Experiment Videos
Immunopathology of in situ seminoma
Insights
Lymphocytes in human testicular seminomas show low activity and limited apoptosis. Immune-suppressing mechanisms may be at play, as no specific lymphocyte types were found to be dominant in either in situ or invasive tumors.
Area of Science:
- Immunology
- Oncology
- Human Pathology
Background:
- The immune microenvironment of testicular tumors, particularly seminoma, is complex.
- Understanding lymphocyte infiltration is crucial for comprehending tumor immunology and potential therapeutic targets.
Purpose of the Study:
- To investigate the composition, activity, and apoptosis of lymphocytes within seminomatous human testes.
- To compare lymphocytes in immune-privileged seminiferous tubules with in situ seminoma versus invasive seminomas.
Main Methods:
- Immunohistochemistry was employed to identify lymphocyte populations (CD4+, CD8+ T cells, B cells, T gamma/delta, NK cells).
- DNA fragmentation detection was used to assess lymphocyte apoptosis.
- Expression of IL-2-R, FasL, and perforin was analyzed to determine lymphocyte activity.
Main Results:
- Equal proportions of CD4+ and CD8+ T cells and B cells (approximately 30% each) were observed.
- T gamma/delta and NK cells were present in very low numbers.
- Low expression levels of IL-2-R, FasL, and perforin indicated limited lymphocyte activity.
- Lymphocyte apoptosis was minimal.
- No significant differences in composition, activity, or apoptosis were found between lymphocytes in in situ and invasive seminomas.
Conclusions:
- The study suggests a lack of specifically committed lymphocytes or the presence of potent immune-suppressing mechanisms, potentially beyond FasL, within the seminoma microenvironment.
- These findings highlight the immune privilege and regulatory processes within the human testis in the context of seminoma.
Abstract:
In this study of the seminomatous human testis the composition, activity and apoptosis of lymphocytes infiltrating the immune-privileged seminiferous tubules with in situ seminoma were studied by immunohistochemistry and DNA fragmentation detection. Likewise the lymphocytes infiltrating the invasive seminomas were studied. The study showed equal numbers of CD4+ and CD8+ T cells and B cells, about 30% of the cells. Very few T gamma/delta and NK cells were present. The activity in terms of IL-2-R, FasL and perforin expression was low. Apoptosis of the lymphocytic cells was limited. No differences were observed between the lymphocytes in seminiferous tubules with in situ seminoma and the lymphocytes in invasive tumours. The study suggests that either specifically committed lymphocytes are not present or, if present, immune-suppressing mechanisms in addition to FasL may be working.